Owens & Minor Stock (NYSE:OMI)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.46

52W Range

$1.91 - $15.54

50D Avg

$3.10

200D Avg

$5.77

Market Cap

$207.07M

Avg Vol (3M)

$2.22M

Beta

1.36

Div Yield

-

OMI Company Profile


Owens & Minor, Inc., along with its affiliated entities, operates as a global provider of healthcare solutions, serving markets both within the United States and internationally. Its business is structured into two primary divisions: Global Solutions and Global Products. The Global Solutions segment delivers a comprehensive array of products and services tailored for healthcare providers and manufacturers. This includes a range of medical and surgical provisions, encompassing both well-known brands and O&M's own proprietary items. Additionally, this division offers crucial services to healthcare providers, such as supplier management, data analytics, inventory control, and clinical supply oversight. It also develops various programs to provide logistical support and marketing strategies for its network of suppliers. Conversely, the Global Products segment focuses on manufacturing and procuring medical and surgical items designed to prevent infections acquired in healthcare settings, serving both acute care facilities and alternative site channels. Its diverse product portfolio features sterilization wraps, surgical drapes and gowns, facial protection gear, various protective apparel, medical examination gloves, customized and minor procedure kits, among other essential medical supplies. O&M supplies its extensive range of offerings directly to a broad client base, which includes large multi-facility healthcare provider networks, independent hospitals, surgical centers, physician's practices, and hospital systems. Distribution also occurs indirectly through collaborations with third-party partners. Founded in 1882, the company maintains its principal corporate office in Richmond, Virginia.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

23,200

IPO Date

Mar 17, 1980

Website

OMI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Product and Service, Other$288.19M--
Wound Care$188.51M--
Urology$116.02M--
Diabetes Product$783.37M--
Patient Direct-$2.68B$2.55B
Products & Healthcare Services-$8.02B$7.78B

Fiscal year ends in Dec 25 | Currency in USD

OMI Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.76B$10.70B$10.33B
Operating Income$27.46M$-207.77M$104.51M
Net Income$-1.10B$-362.69M$-41.30M
EBITDA$27.46M$515.18M$390.57M
Basic EPS-$-4.73$-0.55
Diluted EPS-$-4.73$-0.55

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 11, 26 | 12:00 AM
Q4 25Feb 19, 26 | 5:00 PM
Q3 25Oct 30, 25 | 5:00 PM

Peer Comparison


TickerCompany
BIOABioAge Labs, Inc.
EDITEditas Medicine, Inc.
SGHTSight Sciences, Inc.
ACRSAclaris Therapeutics, Inc.
ALLOAllogene Therapeutics, Inc.
CGCCanopy Growth Corporation
CABACabaletta Bio, Inc.
OMOutset Medical, Inc.
HITIHigh Tide Inc.
CVRXCVRx, Inc.